390
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018)

ORCID Icon, ORCID Icon, , , , , , , , & ORCID Icon show all
Pages 95-114 | Published online: 24 Jan 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA a Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Brończyk-Puzoń A, Koszowska A, Nowak J, Dittfeld A, Bieniek J. Epidemiologia otyłości na świecie i w Polsce. [Epidemiology of obesity in the world and in Poland]. Forum Zaburzen Metabolicznych. 2014;5(1):1–5. Polish.
  • Centrala Narodowego Funduszu Zdrowia, Departament Analiz i Strategii. [Headquarters of the National Health Fund, Department of Analysis and Strategy]. [Homepage on the Internet]. Cukier, otyłość - konsekwencje. Przegląd literatury, szacunki dla Polski. [Sugar, obesity - consequences. Literature review, estimates for Poland]. 2019. Available from: https://pacjent.gov.pl/artykul/cukrzyca-w-liczbach/. Accessed March 29, 2021. Polish.
  • Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. BCTT. 2019;11:151–164. doi:10.2147/bctt.s176070
  • Kamińska M, Ciszewski T, Łopacka-szatan K, Miotła P, Starosławska E. Breast cancer risk factors. Menopause Review Przeglad Menopauzalny. 2015;14(3):196–202. doi:10.5114/pm.2015.54346
  • Nindrea RD, Aryandono T, Lazuardi L. Breast cancer risk from modifiable and non-modifiable risk factors among women in southeast asia: a meta-analysis. Asian Pac J Cancer Prev. 2017;18(12). doi:10.22034/APJCP.2017.18.12.3201
  • Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789. doi:10.1002/ijc.33588
  • Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical cancer: a case-control study. Asia-Pacific Journal of Oncology Nursing. 2019;6(3):308. doi:10.4103/apjon.apjon_73_18
  • Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer. 2020;32(6):720–728. doi:10.21147/j.issn.1000-9604.2020.06.05
  • Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978–2013. JNCI. 2017;110(4):354–361. doi:10.1093/jnci/djx214
  • Ali AT. Risk factors for endometrial cancer. Ceska Gynekologie. 2013;78(5):548.
  • Wentzensen N, Poole EM, Trabert B, et al. Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. JCO. 2016;34(24):2888–2898. doi:10.1200/jco.2016.66.8178
  • Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. IJWH. 2019;11:287–299. doi:10.2147/ijwh.s197604
  • Duong TH, Flowers LC. Vulvo-Vaginal Cancers: risks, Evaluation, Prevention and Early Detection. Obstet Gynecol Clin North Am. 2007;34(4):783–802. doi:10.1016/j.ogc.2007.10.003
  • Krajowy Rejestr Nowotworów, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy. [Polish National Cancer Registry]. [Homepage on the Internet]. Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. [Cases and deaths from malignant neoplasms in Poland]. Available from: http://onkologia.org.pl/. Accessed March 29, 2021. Polish.
  • Centers for Disease Control and Prevention. National Center for Health Statistics. [Homepage on the Internet]. Classification of Diseases, Functioning, and Disability. Available from: https://www.cdc.gov/nchs/icd/index.htm/. Accessed March 29, 2021.
  • Joinpoint Trend Analysis Software. [Homepage on the Internet]. Available from: https://surveillance.cancer.gov/joinpoint/. Accessed March 29, 2021.
  • Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Statist Med. 2009;28(29):3670–3682. doi:10.1002/sim.3733
  • National Cancer Institute. [Homepage on the Internet]. Methodology for characterizing trends, cancer trends progress report. Available from: https://progressreport.cancer.gov/methodology/. Accessed October 8, 2021.
  • Polish National Statistical Office. [Homepage on the Internet]. Dzietność kobiet w latach 1960–2019. [Women’s fertility in 1960–2019.]. Available from: https://stat.gov.pl/obszary-tematyczne/ludnosc/ludnosc/struktura-ludnosci,16,1.html/. Accessed April 13, 2021.
  • Durda‐Masny M, Szwed A, Litwiniuk Z, et al. Time intervals between the age at menarche and the onset of sexual activity in Polish women born between 1959 and 2001. Am J Hum Biol. 2020;33(1). doi:10.1002/ajhb.23436
  • Raglan O, Kalliala I, Markozannes G, et al. Risk factors for endometrial cancer: an umbrella review of the literature. Int J Cancer. 2019;145(7):1719–1730. doi:10.1002/ijc.31961
  • Menon U, Karpinskyj C, Gentry-Maharaj A. Ovarian Cancer Prevention and Screening. Obstet Gynecol. 2018;131(5):909–927. doi:10.1097/aog.0000000000002580
  • Boussios S, Moschetta M, Tatsi K, Tsiouris AK, Pavlidis N. A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: diagnostic and therapeutic perspectives. J Adv Res. 2018;12:1–9. doi:10.1016/j.jare.2018.02.006
  • Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9945):766–781. doi:10.1016/s0140-6736(14)60460-8
  • Didkowska J, Wojciechowska U. Breast cancer in Poland and Europe - Population and statistics Introduction. Nowotwory. 2013;63(2):154.
  • Serwis Rzeczypospolitej Polskiej – Ministerstwo Zdrowia [Polish Ministry of Health]. [Homepage on the Internet]. Programy lekowe – choroby onkologiczne. [Drug programs - oncological diseases]. Available from: https://www.gov.pl/web/zdrowie/choroby-onkologiczne/. Accessed October 9, 2021.
  • Boussios S, Moschetta M, Zarkavelis G, Papadaki A, Kefas A, Tatsi K. Ovarian sex-cord stromal tumours and small cell tumours: pathological, genetic and management aspects. Crit Rev Oncol Hematol. 2017;120:43–51. doi:10.1016/j.critrevonc.2017.10.007
  • Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–296. doi:10.3322/caac.21456
  • Czerw A, Banas T, Juszczyk G, Pitynski K, Nieweglowska D, Ludwin A. Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980–2013): an analysis of population-based data in relation to socio-economic changes. OTT. 2016;9:5521–5530. doi:10.2147/ott.s112187
  • Berkemeyer S, Lemke D, Hense HW. Incidence and mortality trends in German women with breast cancer using age, period and cohort 1999 to 2008. PLoS One. 2016;11(3):e0150723. doi:10.1371/journal.pone.0150723
  • Kvåle R, Myklebust TA, Engholm G, Heinävaara S, Wist E, Møller B. Prostate and breast cancer in four Nordic countries: a comparison of incidence and mortality trends across countries and age groups 1975–2013. Int J Cancer. 2017;141(11):2228–2242. doi:10.1002/ijc.30924
  • Barchuk A, Bespalov A, Huhtala H, et al. Breast and cervical cancer incidence and mortality trends in Russia 1980–2013. Cancer Epidemiol. 2018;55:73–80. doi:10.1016/j.canep.2018.05.008
  • Wojtyla C, Bertuccio P, Wojtyla A, La Vecchia C. European trends in breast cancer mortality, 1980–2017 and predictions to 2025. Eur J Cancer. 2021;152:4–17. doi:10.1016/j.ejca.2021.04.026
  • Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality in Europe. The Breast. 2017;36:89–95. doi:10.1016/j.breast.2017.06.003
  • Malvezzi M, Carioli G, Rodriguez T, Negri E, La Vecchia C. Global trends and predictions in ovarian cancer mortality. Annals of Oncology. 2016;27(11):2017–2025. doi:10.1093/annonc/mdw306
  • Khazaei Z, Goodarzi E, Sohrabivafa M, Naemi H, Mansori K. Association between the incidence and mortality rates for corpus uteri cancer and human development index (HDI): a global ecological study. Obstet Gynecol Sci. 2020;63(2):141–149. doi:10.5468/ogs.2020.63.2.141
  • Henley SJ, Miller JW, Dowling NF, Benard VB, Richardson LC. Uterine Cancer Incidence and Mortality — United States, 1999–2016. MMWR Morb Mortal Wkly Rep. 2018;67(48):1333–1338. doi:10.15585/mmwr.mm6748a1
  • Safaeian M, Solomon D, Castle PE. Cervical Cancer Prevention—Cervical Screening: science in Evolution. Obstet Gynecol Clin North Am. 2007;34(4):739–760. doi:10.1016/j.ogc.2007.09.004
  • Hansen BT, Campbell S, Nygård M. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway. BMJ Open. 2018;8(2):e019005. doi:10.1136/bmjopen-2017-019005
  • National Cancer Institute. [Homepage on the Internet]. SEER*Explorer: an interactive website for SEER cancer statistics Surveillance Research Program. Available from: https://seer.cancer.gov/explorer/. Accessed April 15, 2021.
  • Berrington De González A, Green J. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8097 women with squamous cell carcinoma and 1374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 2006;120(4):885–891. doi:10.1002/ijc.22357
  • Brinton L, Nasca P, Mallin K, Baptiste M, Wilbanks G, Richart R. Case-control study of cancer of the vulva. Int J Gynecol Obstet. 1990;33(4):381. doi:10.1016/0020-7292(90)90543-t
  • Daling JR, Madeleine MM, Schwartz SM, et al. A population-based study of squamous cell vaginal cancer: HPV and Cofactors. Gynecol Oncol. 2002;84(2):263–270. doi:10.1006/gyno.2001.6502
  • Durda-Masny M, Jarząbek-Bielecka G, Szwed A, Hanć T, Czapla Z, Kaczmarek M. Trends over time in age at sexual debut among Polish women and underlying socio-economic determinants. Anthr Anz. 2018;75(3):185–191. doi:10.1127/anthranz/2018/0853
  • Kurdgelashvili G, Dores GM, Srour SA, Chaturvedi AK, Huycke MM, Devesa SS. Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007. Cancer. 2013;119(12):2291–2299. doi:10.1002/cncr.27989
  • Yagi A, Ueda Y, Kakuda M, et al. Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry. Medicine. 2017;96(32):e7751. doi:10.1097/md.0000000000007751
  • Robinson D, Coupland V, Møller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer. 2009;100(3):527–531. doi:10.1038/sj.bjc.6604871
  • Buttmann-Schweiger N, Klug SJ, Luyten A, et al. Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999–2011. A population-based cancer registry analysis. PLoS One. 2015;10(5). doi:10.1371/journal.pone.0128073
  • Lai J, Elleray R, Nordin A, et al. Vulval cancer incidence, mortality and survival in England: age-related trends. BJOG. 2013;121(6):728–738. doi:10.1111/1471-0528.12459
  • Meltzer-Gunnes CJ, Småstuen MC, Kristensen GB, Tropé CG, Lie AK, Vistad I. Vulvar carcinoma in Norway: a 50-year perspective on trends in incidence, treatment and survival. Gynecol Oncol. 2017;145(3):543–548. doi:10.1016/j.ygyno.2017.03.008
  • Schuurman MS, van den Einden LCG, Massuger LFAG, Kiemeney LA, van der Aa MA, de Hullu JA. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer. 2013;49(18):3872–3880. doi:10.1016/j.ejca.2013.08.003
  • Baandrup L, Varbo A, Munk C, Johansen C, Frisch M, Kjaer SK. In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978–2007—a nationwide population-based study. Gynecol Oncol. 2011;122(1):45–49. doi:10.1016/j.ygyno.2011.03.016
  • Barlow EL, Kang Y-J, Hacker NF, Canfell K. Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia Since 1982. Int J Gynecol Cancer. 2015;25(9):1683–1689. doi:10.1097/igc.0000000000000547
  • Mancini S, Bucchi L, Baldacchini F, et al. Incidence trends of vulvar squamous cell carcinoma in Italy from 1990 to 2015. Gynecol Oncol. 2020;157(3):656–663. doi:10.1016/j.ygyno.2020.03.013
  • Xi LF, Koutsky LA, Castle PE, et al. Relationship Between Cigarette Smoking and Human Papilloma Virus Types 16 and 18 DNA Load. Cancer Epidemiol Biomarkers Prev. 2009;18(12):3490–3496. doi:10.1158/1055-9965.epi-09-0763
  • Madsen BS, Jensen HL, van den Brule AJC, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina—Population-based case–control study in Denmark. Int J Cancer. 2008;122(12):2827–2834. doi:10.1002/ijc.23446
  • Dąbrowska K, Sierosławski J, Wieczorek Ł. Trends in tobacco-related behaviour among young people in Poland from 1995 to 2015 against a background of selected European countries. Alcoholism Drug Addiction. 2018;31(1):65–82. doi:10.5114/ain.2018.78816
  • Li Y, Wang X, Wang W. The Impact of COVID-19 on Cancer. Infect Drug Resist. 2021;14:3809–3816. doi:10.2147/IDR.S324569
  • Pineda E, Sanchez-Romero LM, Brown M, et al. Forecasting Future Trends in Obesity across Europe: the Value of Improving Surveillance. Obes Facts. 2018;11(5):360–371. doi:10.1159/000492115
  • Patel C, Brotherton JM, Pillsbury A, et al. The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Euro Surveill. 2018;23(41):1700737. doi:10.2807/1560-7917.ES.2018.23.41.1700737